Last year, BioNTech’s CEO took home more than $150 million. That’s more than anyone else in the health industry, but his peers aren’t far off.

For the first time in 30 years, the American Academy of Pediatrics is substantially diverging from U.S. government vaccine ...

Pfizer said Health Canada has approved its latest COVID-19 vaccine that targets a new Omicron variant. It will be made available in the fall.